MCKESSON CORPORATION Federal Contracts — Government Award History
Total (All Time)$43.8B
Recent FY$8.2B
Top Agency
MCKESSON CORPORATION has received $43.8B in total federal contract awards.
Primary awarding agency: .
Data source: USASpending.gov
Awards by Fiscal Year
| Year | Total | Contracts | Top Agency |
|---|---|---|---|
| FY2026 | $8216.8M | 7 | — |
| FY2025 | $11449.6M | 12 | — |
| FY2024 | $8608.3M | 12 | — |
| FY2023 | $9215.9M | 12 | — |
| FY2022 | $6312.5M | 9 | — |
Recent Contracts
| Date | Agency | Amount | Description |
|---|---|---|---|
| 2025-11-01 | $1406.9M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER | |
| 2026-04-01 | $1191.3M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 APRIL | |
| 2025-10-01 | $1184.2M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER | |
| 2025-09-01 | $1177.9M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 SEPTEMBER | |
| 2026-03-01 | $1175.7M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MARCH | |
| 2025-07-01 | $1118.0M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 JULY | |
| 2025-12-01 | $1110.4M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER | |
| 2026-01-01 | $1088.0M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY | |
| 2025-08-01 | $1075.4M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 AUGUST | |
| 2026-02-01 | $1060.3M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 FEBRUARY | |
| 2024-10-01 | $1048.0M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 OCTOBER | |
| 2025-04-01 | $1045.9M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 APRIL | |
| 2025-05-01 | $1043.5M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 MAY | |
| 2025-06-01 | $1020.3M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 JUNE | |
| 2025-03-01 | $1000.0M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 MARCH | |
| 2024-07-01 | $971.8M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 JULY | |
| 2024-09-01 | $953.2M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 SEPTEMBER | |
| 2024-08-01 | $943.8M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 AUGUST | |
| 2024-11-01 | $912.0M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 NOVEMBER | |
| 2023-09-01 | $902.0M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2023 SEPTEMBER |